| Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor‐negative breast cancer J Wang, A Shidfar, D Ivancic, M Ranjan, L Liu, MR Choi, V Parimi, ... International journal of cancer 140 (11), 2484-2497, 2017 | 51 | 2017 |
| KRAS mutation and epithelial–macrophage interplay in pancreatic neoplastic transformation F Bishehsari, L Zhang, U Barlass, NZ Preite, S Turturro, MS Najor, ... International journal of cancer 143 (8), 1994-2007, 2018 | 28 | 2018 |
| Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin SB Turturro, MS Najor, CE Ruby, MA Cobleigh, AM Abukhdeir Breast Cancer Research and Treatment 156, 33-43, 2016 | 27 | 2016 |
| Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway SB Turturro, MS Najor, T Yung, L Portt, CS Malarkey, AM Abukhdeir, ... Breast Cancer Research and Treatment 177, 325-333, 2019 | 19 | 2019 |
| Contribution of each Trp residue toward the intrinsic fluorescence of the Giα1 protein MS Najor, KW Olsen, DJ Graham, D Mota de Freitas Protein Science 23 (10), 1392-1402, 2014 | 8 | 2014 |
| Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells M DiScala, MS Najor, T Yung, D Morgan, AM Abukhdeir, MA Cobleigh PLoS One 15 (6), e0234146, 2020 | 6 | 2020 |
| Folding of Gα Subunits: Implications for Disease States M Najor, BD Leverson, JL Goossens, S Kothawala, KW Olsen, ... ACS omega 3 (10), 12320-12329, 2018 | 4 | 2018 |
| STAT6 expression and trastuzumab resistance in HER2+ breast cancer. MA Cobleigh, M DiScala, MS Najor, T Yung, AM Abukhdeir Journal of Clinical Oncology 38 (15_suppl), e13006-e13006, 2020 | 1 | 2020 |
| Method of Treatment Utilizing a Gene Expression Signature Predicting the Response of HER2-Directed Therapies AM Abukhdeir, M Cobleigh, M Najor US Patent App. 17/040,314, 2021 | | 2021 |
| Abstract PS18-30: Loss of NF1 leads to rho GTPase activation and sensitivity to multiple agents in breast cancer MA Cobleigh, M Najor, S Brar, S Turturro, L Portt, T Yung, AM Abukhdeir Cancer Research 81 (4_Supplement), PS18-30-PS18-30, 2021 | | 2021 |
| Effect of the loss of NF1 in breast cancer on pathway activation. AM Abukhdeir, MS Najor, S Brar, S Turturro, L Portt, T Yung, MA Cobleigh Journal of Clinical Oncology 36 (15_suppl), e24284-e24284, 2018 | | 2018 |
| Abstract P2-09-30: A gene expression signature that predicts for trastuzumab response in HER2+ breast cancer AM Abukhdeir, MS Najor, SB Turturro, AR Armstrong, A McDonald, ... Cancer Research 78 (4_Supplement), P2-09-30-P2-09-30, 2018 | | 2018 |
| Abstract P6-11-17: Mutations in PIK3R1 activate multiple pathways in breast cancer AM Abukhdeir, SB Turturro, MS Najor, SS Brar, MA Cobleigh Cancer Research 77 (4_Supplement), P6-11-17-P6-11-17, 2017 | | 2017 |
| Abstract P5-05-07: Elucidating molecular resistance to trastuzumab using next generation sequencing in isogenic cell models AM Abukhdeir, M Najor, S Turturro, MR Pergande, JA Borgia, HG Khalak, ... Cancer Research 75 (9_Supplement), P5-05-07-P5-05-07, 2015 | | 2015 |
| Contribution of each Trp residue towards the intrinsic fluorescence of the G (i alpha 1) protein DM de Freitas, MS Najor, KW Olsen, DJ Graham JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY 19, S754-S754, 2014 | | 2014 |
| Biophysical Characterization of Tryptophan Locales, Mg²+ Binding and Protein Folding in Gα Subunits M Najor | | 2013 |
